Clinical Trial Update: A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human study of CKD-703 in advanced solid tumors and non-small cell lung cancer is currently recruiting in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CKD-703

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Advanced Solid Tumors, Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING